The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 15 October 2001. doi:10.1084/jem.194.8.1033
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 356K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Irjala, H.
Right arrow Articles by Jalkanen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Irjala, H.
Right arrow Articles by Jalkanen, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2001/10/1033/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 8, October 15, 2001 1033-1042

Original Article

Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium

Heikki Irjalaa, Eva-Liz Johanssona, Reidar Grenmanb, Kalle Alanenc, Marko Salmia, and Sirpa Jalkanena

a MediCity Research Laboratory, Department of Medical Microbiology, and National Public Health Institute, Department in Turku, and the Departments of
b Otorhinolaryngology–Head and Neck Surgery, University of Turku, FIN-20520 Turku, Finland
c Pathology, University of Turku, FIN-20520 Turku, Finland
MediCity Research Laboratory, University of Turku, Tykistokatu 6, FIN-20520 Turku, Finland.358-2-333-7000358-2-333-7007

sirpa.jalkanen{at}utu.fi

Continuous lymphocyte recirculation between blood and lymphoid tissues forms a basis for the function of the immune system. Lymphocyte entrance from the blood into the tissues has been thoroughly characterized, but mechanisms controlling lymphocyte exit from the lymphoid tissues via efferent lymphatics have remained virtually unknown. In this work we have identified mannose receptor (MR) on human lymphatic endothelium and demonstrate its involvement in binding of lymphocytes to lymphatic vessels. We also show that the binding requires L-selectin, and L-selectin and MR form a receptor–ligand pair. On the other hand, L-selectin binds to peripheral lymph node addressins (PNAds) on high endothelial venules (HEVs) that are sites where lymphocytes enter the lymphatic organs. Interestingly, MR is absent from HEVs and PNAds from lymphatic endothelium. Thus, lymphocyte L-selectin uses distinct ligand molecules to mediate binding at sites of lymphocyte entrance and exit within lymph nodes. Taken together, interaction between L-selectin and MR is the first molecularly defined mechanism mediating lymphocyte binding to lymphatic endothelium.

Key Words: lymphatics • lymphocyte recirculation • cancer metastasis • endothelium • lymph node

H. Irjala and E.-L. Johansson contributed equally to this paper.

Abbreviations used in this paper: HEV, high endothelial venule; MR, mannose receptor; PNAd, peripheral lymph node addressin; VEGFR, vascular endothelial growth factor receptor.

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS